• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子与β细胞生物学:从概念到临床转化

Cytokines and beta-cell biology: from concept to clinical translation.

作者信息

Donath Marc Y, Størling Joachim, Berchtold Lukas A, Billestrup Nils, Mandrup-Poulsen Thomas

机构信息

The Clinic for Endocrinology and Diabetes, University Hospital Zurich, Zurich, Switzerland.

出版信息

Endocr Rev. 2008 May;29(3):334-50. doi: 10.1210/er.2007-0033. Epub 2007 Nov 29.

DOI:10.1210/er.2007-0033
PMID:18048762
Abstract

The tale of cytokines and the beta-cell is a long story, starting with in vitro discovery in 1984, evolving via descriptive and phenomenological studies to detailed mapping of the signalling pathways, gene- and protein expression patterns, molecular and biochemical effector mechanisms to in vivo studies in spontaneously diabetic and transgenic animal models. Only very recently have steps been taken to translate the accumulating compelling preclinical data into clinical trials. The aim of this chapter is to present an overview of early and recent key observations from our own groups as well as other laboratories that serve to illuminate the road from concept to clinical translation.

摘要

细胞因子与β细胞的故事由来已久,始于1984年的体外发现,历经描述性和现象学研究,发展到信号通路、基因和蛋白质表达模式、分子及生化效应机制的详细图谱绘制,再到自发性糖尿病和转基因动物模型的体内研究。直到最近才开始采取措施将积累的令人信服的临床前数据转化为临床试验。本章旨在概述我们自己的团队以及其他实验室早期和近期的关键观察结果,这些结果有助于阐明从概念到临床转化的道路。

相似文献

1
Cytokines and beta-cell biology: from concept to clinical translation.细胞因子与β细胞生物学:从概念到临床转化
Endocr Rev. 2008 May;29(3):334-50. doi: 10.1210/er.2007-0033. Epub 2007 Nov 29.
2
The anti-interleukin-1 in type 1 diabetes action trial--background and rationale.1型糖尿病抗白细胞介素-1作用试验——背景与理论依据
Diabetes Metab Res Rev. 2009 May;25(4):321-4. doi: 10.1002/dmrr.960.
3
Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.胰岛炎症损害 2 型糖尿病中的胰腺β细胞。
Physiology (Bethesda). 2009 Dec;24:325-31. doi: 10.1152/physiol.00032.2009.
4
TNF receptor 1 deficiency increases regulatory T cell function in nonobese diabetic mice.TNF 受体 1 缺乏症增加非肥胖型糖尿病小鼠调节性 T 细胞的功能。
J Immunol. 2011 Aug 15;187(4):1702-12. doi: 10.4049/jimmunol.1100511. Epub 2011 Jul 6.
5
Use of a systems biology approach to understand pancreatic beta-cell death in Type 1 diabetes.运用系统生物学方法理解1型糖尿病中胰腺β细胞死亡
Biochem Soc Trans. 2008 Jun;36(Pt 3):321-7. doi: 10.1042/BST0360321.
6
Insulin-producing intestinal K cells protect nonobese diabetic mice from autoimmune diabetes.产生胰岛素的肠道 K 细胞可保护非肥胖型糖尿病小鼠免受自身免疫性糖尿病的侵害。
Gastroenterology. 2014 Jul;147(1):162-171.e6. doi: 10.1053/j.gastro.2014.03.020. Epub 2014 Mar 21.
7
Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage.1型糖尿病治疗进展:免疫调节与β细胞挽救
Endocrinol Metab Clin North Am. 2009 Jun;38(2):303-17, viii. doi: 10.1016/j.ecl.2009.01.005.
8
Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?2型糖尿病患儿的β细胞自身抗体:亚组还是误诊?
Arch Dis Child. 2006 Jun;91(6):473-7. doi: 10.1136/adc.2005.088229. Epub 2006 Jan 31.
9
Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.超越激素:1 型糖尿病中的胰岛素作为自身免疫靶点。
Endocr Rev. 2011 Oct;32(5):623-69. doi: 10.1210/er.2011-0010. Epub 2011 Jun 23.
10
Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.细胞因子在自身免疫 1 型糖尿病中对胰岛β细胞的免疫调节和再生。
J Interferon Cytokine Res. 2011 Oct;31(10):711-9. doi: 10.1089/jir.2011.0025. Epub 2011 Aug 18.

引用本文的文献

1
BET bromodomain inhibitors attenuate transcription of a subset of IL-1-induced NF-κB targets that promote inflammation in β-cells.BET溴结构域抑制剂可减弱白细胞介素-1诱导的促进β细胞炎症的一部分核因子-κB靶标的转录。
J Biol Chem. 2025 Jul;301(7):110358. doi: 10.1016/j.jbc.2025.110358. Epub 2025 Jun 10.
2
Impact of DPP-4 Inhibitors on Interleukin Levels in Type 2 Diabetes Mellitus.二肽基肽酶-4抑制剂对2型糖尿病患者白细胞介素水平的影响
J Clin Endocrinol Metab. 2025 Mar 17;110(4):1195-1204. doi: 10.1210/clinem/dgae783.
3
Multi-omic human pancreatic islet endoplasmic reticulum and cytokine stress response mapping provides type 2 diabetes genetic insights.
多组学人类胰腺胰岛内质网和细胞因子应激反应图谱为 2 型糖尿病的遗传见解提供了依据。
Cell Metab. 2024 Nov 5;36(11):2468-2488.e7. doi: 10.1016/j.cmet.2024.09.006. Epub 2024 Oct 8.
4
GHSR Deletion in β-Cells of Male Mice: Ineffective in Obesity, but Effective in Protecting against Streptozotocin-Induced β-Cell Injury in Aging.GHSR 在雄性小鼠β 细胞中的缺失:在肥胖中无效,但在衰老时可有效保护链脲佐菌素诱导的β 细胞损伤。
Nutrients. 2024 May 13;16(10):1464. doi: 10.3390/nu16101464.
5
Detrimental Actions of Chlorinated Nucleosides on the Function and Viability of Insulin-Producing Cells.氯化核苷对胰岛素分泌细胞功能和活力的有害作用。
Int J Mol Sci. 2023 Sep 26;24(19):14585. doi: 10.3390/ijms241914585.
6
Reactive oxygen species: role in obesity and mitochondrial energy efficiency.活性氧物种:在肥胖症和线粒体能量效率中的作用。
Philos Trans R Soc Lond B Biol Sci. 2023 Sep 11;378(1885):20220210. doi: 10.1098/rstb.2022.0210. Epub 2023 Jul 24.
7
Regulatory mechanisms of kaempferol on iNOS expression in RINm5F β-cells under exposure to interleukin-1β.山奈酚对暴露于白细胞介素-1β的RINm5Fβ细胞中诱导型一氧化氮合酶表达的调控机制
Heliyon. 2023 Mar 23;9(4):e14818. doi: 10.1016/j.heliyon.2023.e14818. eCollection 2023 Apr.
8
Effects of anti-inflammatory therapies on glycemic control in type 2 diabetes mellitus.抗炎疗法对 2 型糖尿病患者血糖控制的影响。
Front Immunol. 2023 Mar 1;14:1125116. doi: 10.3389/fimmu.2023.1125116. eCollection 2023.
9
Compound A attenuates proinflammatory cytokine-induced endoplasmic reticulum stress in beta cells and displays beneficial therapeutic effects in a mouse model of autoimmune diabetes.化合物 A 可减轻β细胞中促炎细胞因子诱导的内质网应激,并在自身免疫性糖尿病小鼠模型中显示出有益的治疗效果。
Cell Mol Life Sci. 2022 Nov 12;79(12):587. doi: 10.1007/s00018-022-04615-5.
10
Macrophages and neutrophils are necessary for ER stress-induced β cell loss.巨噬细胞和中性粒细胞对于内质网应激诱导的β细胞损失是必要的。
Cell Rep. 2022 Aug 23;40(8):111255. doi: 10.1016/j.celrep.2022.111255.